MAP2K7 and neoplasm: Moreover, NF1 WT human Schwann cells are not sensitive to this combination, suggesting the NF1 loss tumor cells are uniquely responsive to simultaneous targeting of RAF dimerization and MEK, and the central role of ERK signaling in driving NF1-MPNST.